Trialect

Active

Assessing cognitive decline and dementia

Brain Matters institute

Brian Matters Institute

Main Areas of Interest

Faculty: Dr Alexandra Pentaraki BA, MSc, PhD, CPsychol, AFBPsS

Clinical Psychologist & Neuropsychologist for children and adults-Lecturer-Registered Expert Witness in European Courts & in The International Criminal Court, The Hague

Hon. Lecturer, Applied Psychology & Mental Health, University of Liverpool (Online), UK (2012-2017) & Faculty, Psychology Department, University of Essex (Online), UK, (2018-2019); Faculty, New School of Counselling & Psychotherapy (NSCP)-Middlesex University, (2019-present)

Visiting Research Associate and Alumna, IoPPN, King's College London

Mode: e-mail, Skype

Lecturing and Teaching: The aim of the seminar is to train participants in assessing potential cognitive decline in adults and in the elderly and/or people that are suspected to have a mild to serious cognitive decline. The course is based on the instrument IQCODE and it lasts two weeks. The IQCODE was developed and standardized in 1994 by experts on cognitive decline in the elderly such as Jorm A.F. Since then further data on the validity of the IQCODE have been published increasing the diagnostic power of the test (Jorm, Broe, Creasey et al., 1994). Dr Pentaraki has recently translated and adapted the IQCODE into Greek (Pentaraki, 2012). Participants will be taught the IQCODE and a supplementary technique that increases the reliability and validity of diagnosing cognitive decline and dementia. It is also based on short readings and assignments that aim to increase academic and clinical knowledge in the instrument and in dementia and mild cognitive decline. This clinical workshop is designed for psychologists, neuropsychologists, psychiatrists, psychotherapists, social workers, GPs, occupational therapists, nurses, neuroscientists.

Techniques You Will Learn

Learning Outcomes:

Understand the major differences between dementia and ‘pseudodementia’
Understand the differences between Mild Cognitive Decline and Dementia
Discuss the way the IQCODE and the technique DEMEGRAPH can help in increasing the reliability and validity of the diagnosis of dementia
Explain what exactly the MMSE shows to clinicians
Train in the use of IQCODE, DEMEGRAPH and MMSE.

Learning and Teaching Resources:

American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (DSM-5®). American Psychiatric Pub.

American Psychiatric Association (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington DC: American Psychiatric Association.

Jorm, A. F., Broe, G.A., Creasey, H., et al. (1996). Further data on the validity of the Informant Questionnaire on Cognitive Decline in the Elderly (IQ-CODE).International Journal Geriatric Psychiatry, 11, 131-139.

Jorm, A. F. (1994). A short form of the Informant Questionnaire on Cognitive

Decline in the Elderly (IQCODE): Development and cross-validation. Psychological Medicine, 24, 145-153.

Lezak, D. M., Howieson, B. D., Loring, W. D., Hannay, H. J., & Fischer, J. S. (2004) (4th ed.). Neuropsychological assessment. Oxford: Oxford University Press.

Modules

Tasks and Timeline:

Module 1 (week 1) Participants will study the two published papers on IQCODE and write up a short summary of these papers in order to understand the theory and research evidence of the assessment. Participants will be taught how to provide the IQCODE & the MMSE and they will need to practice the test to a caregiver, child or partner of an old person.

Module 2 (week 2) Participants will learn how to score the IQCODE and interpret the test. They will learn how to score IQCODE with DemeGraph (a scoring technique that combines the scores of IQCODE and MMSE) in order to increase diagnostic reliability. At the end of week II they will have to answer a short MCQ on the learning material.

Program Fee


Total Number of Modules
Time duration of Each module	minutes
Total Program Cost	$0

This program allows Merit Applications. This program allows merit-based applications for virtual and onsite clinical and research programs. If you are successfully awarded under this category, Trialect or the host mentor will cover the tuition fee only. All applications will be evaluated based on merit. Due to the high level of competition, the chances of being selected under the merit category are quite limited.

Who Can Apply

All are eligible

Host Details

Host Name: Dr. Alexandra Pentaraki

Affiliation: Brain Matters institute

Address: Brain Matters institute, Greece

Website URL: https://scholar.google.com/citations?user=3FerdrYAAAAJ&hl=en

Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.